Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4059 | Training, Tech. Assistance, Quality Assurance/Improvement Wiki | 1.00 |
| drug4051 | Training Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This project will evaluate 3 approaches of implementation support for university peer leaders who will deliver a prevention program with a particularly strong evidence-base compared to changes observed in outcomes in response to usual care at the universities before implementation. This study aims to advance knowledge of this innovative and economical way to provide college prevention programs to reduce the burden of mental illness in the college student population.
Description: Peer educators' adherence to scripted intervention manual and accuracy of script delivery as coded through evaluation of audio-recorded sessions by two clinicians independently coding a random selection of sessions using the Session Adherence Scale. Coders will indicate the extent to which peer leaders adhere to the 25 total total necessary components of the 4-session intervention script using a scoring guide ranging from 10 (indicating no adherence) to 100 (indicating perfect adherence) with a possible total score range of 250 to 2500. Inter-rater agreement for Session Adherence Scale has been found to be .92 (Stice et al., 2013a).
Measure: Fidelity of Program Implementation as assessed by 25-item Session Adherence Scale (Stice et al., 2013a) Time: 12 monthsDescription: Peer educators' competence with intervention delivery as assessed by 12-item Group Leader Competence Scale measuring various indicators of a competent group facilitator (e.g. leaders allot equal speaking time for all members.) Coders will indicate the extent to which peer leaders show competence in their delivery of the scripted intervention across 12 items using a scoring guide ranging from 10 (indicating poor competence) to 100 (indicating superior competence) with a possible total score range of 120 to 1200. Inter-rater agreement for Group Leader Competence Scale has been found to be .96 (Stice et al., 2013a).
Measure: Competence of Program Implementation as assessed by 12-item Group Leader Competence Scale (Stice et al., 2013a) Time: 12 monthsDescription: Attendance levels of participants as recorded by peer educators
Measure: Attendance Time: 12 monthsDescription: Percentage of students who complete the prevention program at 1 year post-educator training
Measure: Reach Time: 12 monthsDescription: Percentage of students who complete the prevention program during the subsequent 2-year sustainability monitoring period
Measure: Sustainability Time: 24 monthsDescription: Dollar amount delivery cost for each arm of the implementation support model
Measure: Delivery Cost Time: 12 monthsDescription: Relative cost-effectiveness of each arm of the implementation support model
Measure: Relative Cost-Effectiveness Time: 12 months, 24 monthsDescription: Perceived Characteristics of the Intervention as measured by the 28-item Provider Intervention Adoption Scale. Respondents will indicate their level of agreements with the 27 items using a 5-point Likert-type scale ranging from 1 ("Strongly Disagree") to 5 ("Strongly Agree) with a possible score ranging from 27 to 135.
Measure: Perceived Characteristics of the Intervention as measured by the 28-item Provider Intervention Adoption Scale Time: 1 Week or less post trainingDescription: Peer educators' declarative project knowledge as measured by the 20-item Body Project Knowledge Scale. Peer educators will indicate whether the statements in this scale are "true" or "false," with a possible score ranging from 0 for no correct replies to 20 for every answer correct.
Measure: Project Knowledge Time: Baseline, 1 week or less post-training, 12 monthsDescription: Provider Attitudes Towards Evidence-Based Interventions as measured by the 50-item Evidence-Based Practice Attitude Scale (EBPAS-50), which will assess provider attitudes toward adopting evidence-based intervention (Aarons, 2004); it has four subscales: Appeal (intuitive appeal of evidence-based interventions), Requirements (likelihood of adopting evidence-based interventions given supervisor, organizational, or system requirements), Openness (general openness to new practices), and Divergence (perceived divergence between research developed interventions and current practice), which sum up to a total score representing respondents' global attitude toward adopting and using evidence-based practice. Respondents will indicate the extent to which they agree with each item on a 5-point Likert scale ranging from 0 (Not at all) to 4 (Very great extent). A higher total score indicates a more positive attitude toward adopting and using evidence-based practice. 23 items are reverse-scored.
Measure: Provider Attitudes Towards Evidence-Based Interventions Time: Baseline, 1 week or less post-training, 12 monthsDescription: Implementation Progress as measured by the Prevention Implementation Progress Scale
Measure: Implementation Progress Time: Baseline, 12 monthsDescription: Peer Educator Self-Efficacy as measured by the 14-item Peer Educator Self-Efficacy Questionnaire. Respondents will degree of confidence on a 6-point scale ranging from 1 (No Confidence) to 6 (Complete Confidence). Scores will range from 14 (no demonstrated peer educator self-efficacy) to 84 (high peer educator self-efficacy.)
Measure: Peer Educator Self-Efficacy Time: Baseline, 1 week or less post-training, 12 monthsDescription: Inner Setting sub domains assessed using the Team Climate Inventory
Measure: Inner Setting Time: Baseline, 12 monthsDescription: Evaluate presence or absence of formal policies related to evidence-based programs, fiscal and other organizational resources for peer educators based on two coded interviews
Measure: Outer Setting Time: BaselineAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports